CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase II Trial of Bevacizumab and Erlotinib in Patients With Advanced Biliary Tumors

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT00356889
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:35:41.783726+00:00
Published At: 2013-05-20T00:00:00+00:00
Record Updated At: 2014-05-28
Results Posted At: 2013-05-20
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Cholangiocarcinoma of the Extrahepatic Bile Duct", "Cholangiocarcinoma of the Gallbladder", "Gastrointestinal Cancer", "Recurrent Extrahepatic Bile Duct Cancer", "Recurrent Gallbladder Cancer", "Unresectable Extrahepatic Bile Duct Cancer", "Unresectable Gallbladder Cancer"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2014-05-28"
protocolSection.identificationModule.nctId: "NCT00356889"
protocolSection.identificationModule.officialTitle: "A Phase II Trial of Bevacizumab and Erlotinib in Patients With Advanced Biliary Tumors"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2013-05-20"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.